New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value LAS VEGAS / Nov 15, 2023 / Business Wire / PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys, Inc. (Nasdaq:FEMY) (“Femasys”), a biomedical company focused on meeting significant unmet needs for women worldwide. Femasys... Read More